Astellas confirmed this morning that the EMA has started its assessment ... options across the disease continuum.” Xtandi is currently approved in the US and Japan for the treatment of ...
“Since its approval, TALZENNA in combination with XTANDI has redefined the standard ... these data have been shared with the European Medicines Agency (EMA) and other global health authorities ...
Hosted on MSN1mon
Pfizer reports survival benefit in prostate cancer studyThe results have been shared with global health authorities, including the FDA and the European Medicines Agency (EMA), to support ... of TALZENNA and XTANDI is now approved in over 40 countries ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback